"beta 2-Microglobulin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An 11-kDa protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.
Descriptor ID |
D001613
|
MeSH Number(s) |
D12.776.124.790.223.100 D12.776.377.715.182.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "beta 2-Microglobulin".
Below are MeSH descriptors whose meaning is more specific than "beta 2-Microglobulin".
This graph shows the total number of publications written about "beta 2-Microglobulin" by people in this website by year, and whether "beta 2-Microglobulin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 2 | 4 |
1995 | 2 | 1 | 3 |
1996 | 1 | 3 | 4 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 2 | 3 |
2000 | 1 | 2 | 3 |
2001 | 1 | 1 | 2 |
2002 | 1 | 3 | 4 |
2003 | 1 | 3 | 4 |
2004 | 0 | 2 | 2 |
2005 | 2 | 0 | 2 |
2006 | 2 | 2 | 4 |
2007 | 3 | 2 | 5 |
2008 | 2 | 5 | 7 |
2009 | 1 | 1 | 2 |
2010 | 3 | 4 | 7 |
2011 | 2 | 0 | 2 |
2012 | 1 | 1 | 2 |
2013 | 1 | 2 | 3 |
2014 | 1 | 2 | 3 |
2015 | 2 | 3 | 5 |
2016 | 1 | 2 | 3 |
2018 | 0 | 1 | 1 |
2019 | 1 | 2 | 3 |
2020 | 0 | 2 | 2 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta 2-Microglobulin" by people in Profiles.
-
B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy. J Immunother. 2022 05 01; 45(4):187-193.
-
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants. Am J Nephrol. 2020; 51(10):797-805.
-
CXCR4 mutational status does not impact outcomes in patients with Waldenstr?m macroglobulinemia treated with proteasome inhibitors. Am J Hematol. 2020 04; 95(4):E95-E98.
-
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells. J Transl Med. 2019 07 24; 17(1):240.
-
Progression Risk Stratification of Asymptomatic Waldenstr?m Macroglobulinemia. J Clin Oncol. 2019 06 01; 37(16):1403-1411.
-
Evidence for a Causal Role of the SH2B3-?2M Axis in Blood Pressure Regulation. Hypertension. 2019 02; 73(2):497-503.
-
Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov. 2018 06; 8(6):730-749.
-
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma. J Clin Oncol. 2018 04 01; 36(10):942-950.
-
Are ultrasound renal aspects associated with urinary biochemistry in fetuses with lower urinary tract obstruction? Prenat Diagn. 2016 Dec; 36(13):1206-1210.
-
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum ?2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model. Br J Haematol. 2016 Oct; 175(2):290-299.